U.S. Markets open in 3 hrs 31 mins

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DNKEY, AXGN and MAXR

NEW YORK, NY / ACCESSWIRE / March 8, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Danske Bank A/S (OTC PINK: DNKEY)
Class Period: Purchasers of American Depositary Receipts between January 9, 2014 and October 23, 2018
Lead Plaintiff Deadline: March 11, 2019

The complaint alleges that during the class period Danske Bank A/S made materially false and/or misleading statements and/or failed to disclose that: (i) Danske Bank's Estonian branch was facilitating money laundering through at least March 2016; (ii) a whistleblower had reported the Estonian money laundering to the Company in 2013; (iii) Denmark's Financial Supervisory Authority (the "DFSA") had been investigating the Estonian money laundering since 2014; (iv) Danske Bank had concealed the results of its own internal investigation from the DFSA, further exposing it to regulatory action and fines; (v) Danske Bank had been overstating its historical profits by including the profits derived from its illicit Estonian operations; and (vi) Danske Bank lacked effective internal and reporting controls.

Get additional information about the DNKEY lawsuit: http://www.kleinstocklaw.com/pslra-1/danske-bank-a-s-loss-submission-form?wire=3

AxoGen, Inc. (AXGN)
Class Period: August 7, 2017 to December 18, 2018
Lead Plaintiff Deadline: March 11, 2019

The lawsuit alleges that AxoGen, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company aggressively increased prices to mask lower sales; (2) the Company's pricing alienated customers and threatened the Company's future growth; (3) ambulatory surgery centers form a significant part of the market for the Company's products; (4) such centers were especially sensitive to price increases; (5) the Company was dependent on a small number of surgeons whom the Company paid to generate sales; (6) the Company's consignment model for inventory was reasonably likely to lead to channel stuffing; (7) the Company offered purchase incentives to sales representatives to encourage channel stuffing; (8) the Company's sales representatives were encouraged to backdate revenue to artificially inflate metrics; (9) the Company lacked adequate internal controls to prevent such channel stuffing and backdating of revenue; (10) the Company's key operating metrics, such as number of active accounts, were overstated; and (11) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Get additional information about the AXGN lawsuit: http://www.kleinstocklaw.com/pslra-1/axogen-inc-loss-submission-form?wire=3.

Maxar Technologies Inc. (MAXR)
Class Period: March 29, 2018 to January 7, 2019
Lead Plaintiff Deadline: March 15, 2019

The complaint alleges Maxar Technologies Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Maxar improperly inflated the value of its intangible assets, among other accounting improprieties; (ii) Maxar's highly-valued WorldView-4 was equipped with CMGs that were faulty and/or ill-suited for their designed and intended purpose; and (iii) as a result, Maxar's public statements were materially false and misleading at all relevant times.

Get additional information about the MAXR lawsuit: http://www.kleinstocklaw.com/pslra-1/maxar-technologies-inc-loss-submission-form?wire=3.

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665 www.kleinstocklaw.com